Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuel Katsanis

Showing results (1-10 of 127) with videos related to

Pageof 13
Sort By:
Bone Marrow Transplantation|September 19, 2017
Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantationYi Zeng, Emmanuel Katsanis
Oncoimmunology|May 4, 2016
Targeted immunotherapy for pediatric solid tumorsLisa M Kopp, Emmanuel Katsanis
Brain, Behavior, and Immunity|April 21, 2020
The immunological case for staying active during the COVID-19 pandemicRichard J Simpson, Emmanuel Katsanis
Clinical & Developmental Immunology|January 24, 2014
The multifaceted role of Th17 lymphocytes and their associated cytokines in cancerDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Oncoimmunology|August 9, 2021
Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?Holly Pariury, Laurel Truscott, Emmanuel Katsanis
Immunotherapy|February 18, 2010
Personalized dendritic cell-based tumor immunotherapyNona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Pediatric Transplantation|September 19, 2019
Transfusion independence after repeated haploidentical hematopoietic cell transplants in a patient with congenital dyserythropoietic anemia type II and hemosiderosisMarci Macaraeg, Maria Proytcheva, Emmanuel Katsanis
Oncoimmunology|July 4, 2012
Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cellsNicolas Larmonier, Bernard Bonnotte, Emmanuel Katsanis
Oncoimmunology|March 22, 2014
Chemotherapeutic targeting of myeloid-derived suppressor cellsDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Cancer Immunology, Immunotherapy : CII|May 12, 2005
Chaperone-rich cell lysates, immune activation and tumor vaccinationYi Zeng, Michael W Graner, Emmanuel Katsanis
Pageof 13

Showing results (1-10 of 127) with videos related to

Sort By:
Pageof 13
Bone Marrow Transplantation|September 19, 2017
Potential niche indications for blinatumomab as a bridge to hematopoietic cell transplantationYi Zeng, Emmanuel Katsanis
Oncoimmunology|May 4, 2016
Targeted immunotherapy for pediatric solid tumorsLisa M Kopp, Emmanuel Katsanis
Brain, Behavior, and Immunity|April 21, 2020
The immunological case for staying active during the COVID-19 pandemicRichard J Simpson, Emmanuel Katsanis
Clinical & Developmental Immunology|January 24, 2014
The multifaceted role of Th17 lymphocytes and their associated cytokines in cancerDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Oncoimmunology|August 9, 2021
Have CD19-directed immunotherapy and haploidentical hematopoietic cell transplantation transformed pediatric B-cell acute lymphoblastic leukemia into a chronic disease?Holly Pariury, Laurel Truscott, Emmanuel Katsanis
Immunotherapy|February 18, 2010
Personalized dendritic cell-based tumor immunotherapyNona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Pediatric Transplantation|September 19, 2019
Transfusion independence after repeated haploidentical hematopoietic cell transplants in a patient with congenital dyserythropoietic anemia type II and hemosiderosisMarci Macaraeg, Maria Proytcheva, Emmanuel Katsanis
Oncoimmunology|July 4, 2012
Cytotoxic and antigen presenting functions of T helper-1-activated dendritic cellsNicolas Larmonier, Bernard Bonnotte, Emmanuel Katsanis
Oncoimmunology|March 22, 2014
Chemotherapeutic targeting of myeloid-derived suppressor cellsDarya Alizadeh, Emmanuel Katsanis, Nicolas Larmonier
Cancer Immunology, Immunotherapy : CII|May 12, 2005
Chaperone-rich cell lysates, immune activation and tumor vaccinationYi Zeng, Michael W Graner, Emmanuel Katsanis
Pageof 13